Carlos A. Zarate Jr.

National Institute of Mental Health

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (18)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (6)

Tomi Rantamäki

University of Helsinki

FINLAND

View details

Konstantinos Fountoulakis

Professor

Aristotle University of Thessaloniki

GREECE

View details

Henrik Samuel Kohtala

University of Helsinki

FINLAND

View details

Ioline Henter

National Institute of Mental Health

UNITED STATES

View details

Mark Kvarta

National Institute of Mental Health

UNITED STATES

View details

Rupert Lanzenberger

Prof. P.D. M.D.

Medical University of Vienna

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Carlos A. Zarate Jr.

Research Interests

Explore related searches

Contact this professor

Articles (18)

The Synergistic Effect of Bupropion-Dextromethorphan With Thyroid Supplementation in Treatment-Resistant Depression

Relative effectiveness of antidepressant treatments in treatment-resistant depression: a systematic review and network meta-analysis of randomized controlled trials

Esketamine in depression: putative biomarkers from clinical research

Pharmacodynamic properties of lumateperone and its efficacy in acute bipolar depression: a mechanistic hypothesis based on data

Carlos A. Zarate, Jr.: Using clinical translational neuroscience to develop the next generation of antidepressant treatments that act more rapidly and effectively

Potential association between suicide risk, aggression, impulsivity, and the somatosensory system

Clinical, behavioral, and electrophysiological profiles along a continuum of suicide risk: evidence from an implicit association task

Antidepressant efficacy of cariprazine in bipolar disorder and the role of its pharmacodynamic properties: A hypothesis based on data

κ-Opioid Receptor Plasma Levels Are Associated With Sex and Diagnosis of Major Depressive Disorder But Not Response to Ketamine

Ketamine treatment for depression: a review

Glutamate modulators and beyond: A neuroscience revolution in the making

Lithium treatment of Bipolar disorder in adults: A systematic review of randomized trials and meta-analyses

A wake-up call: Sleep physiology and related translational discrepancies in studies of rapid-acting antidepressants

Commentary on the Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder

Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status

Response to commentary on the comparative efficacy of esketamine vs. ketamine meta-analysis: Putting the cart before the horse?

Treatment of depression with ketamine does not change plasma levels of brain-derived neurotrophic factor or vascular endothelial growth factor

Ketamine: a new chapter in antidepressant development

Collaborators (6)

Tomi Rantamäki

Konstantinos Fountoulakis

Henrik Samuel Kohtala

Ioline Henter

Mark Kvarta

Rupert Lanzenberger

Make your next move.